MedTrace Logo

Effect of NeuroAD on Alzheimer Patients

NCT01825317 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2014-04-21

No results posted yet for this study

Summary

Non-invasive stimulation of the brain using magnetic and cognitive stimulation by computer for the treatment of Alzheimer patients.

Conditions

Interventions

DEVICE

NeuroAD

synchronized TMS+COGNITIVE TRAINING

DEVICE

Sham device

Sham TMS+cog, has the same sound and appearance as the real device, delivers no energy.

Sponsors & Collaborators

  • company: K The Power

    collaborator UNKNOWN

  • Chungnam National University Hospital

    collaborator OTHER

  • Neuronix Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01825317 on ClinicalTrials.gov